HK1006783A1 - Amorphous piretanide, piretanide polymorphis, process for their preparation and their use - Google Patents

Amorphous piretanide, piretanide polymorphis, process for their preparation and their use

Info

Publication number
HK1006783A1
HK1006783A1 HK98105624A HK98105624A HK1006783A1 HK 1006783 A1 HK1006783 A1 HK 1006783A1 HK 98105624 A HK98105624 A HK 98105624A HK 98105624 A HK98105624 A HK 98105624A HK 1006783 A1 HK1006783 A1 HK 1006783A1
Authority
HK
Hong Kong
Prior art keywords
piretanide
pct
sec
peak
date
Prior art date
Application number
HK98105624A
Other languages
English (en)
Inventor
Yuji Chikaraishi
Yoshihisa Matsuda
Makoto Otsuka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03321595A external-priority patent/JP3532987B2/ja
Priority claimed from JP03321695A external-priority patent/JP3532988B2/ja
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of HK1006783A1 publication Critical patent/HK1006783A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98105624A 1995-02-22 1998-06-18 Amorphous piretanide, piretanide polymorphis, process for their preparation and their use HK1006783A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP03321595A JP3532987B2 (ja) 1995-02-22 1995-02-22 新規な無晶形ピレタニドおよびその製造方法
JP03321695A JP3532988B2 (ja) 1995-02-22 1995-02-22 ピレタニドの新規な結晶多形およびその製造方法
PCT/IB1996/000254 WO1996026197A1 (en) 1995-02-22 1996-02-12 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Publications (1)

Publication Number Publication Date
HK1006783A1 true HK1006783A1 (en) 1999-03-19

Family

ID=26371876

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105624A HK1006783A1 (en) 1995-02-22 1998-06-18 Amorphous piretanide, piretanide polymorphis, process for their preparation and their use

Country Status (15)

Country Link
US (1) US6096779A (da)
EP (1) EP0812320B1 (da)
KR (1) KR100419355B1 (da)
CN (1) CN1072215C (da)
AT (1) ATE194607T1 (da)
BR (1) BR9607295A (da)
CA (1) CA2213693C (da)
DE (1) DE69609314T2 (da)
DK (1) DK0812320T3 (da)
ES (1) ES2150105T3 (da)
GR (1) GR3034605T3 (da)
HK (1) HK1006783A1 (da)
MX (1) MX9706339A (da)
PT (1) PT812320E (da)
WO (1) WO1996026197A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
DK1567529T4 (da) 2002-05-16 2021-05-10 Janssen Sciences Ireland Uc Pseudopolymorfe former af en hiv-proteaseinhibitor
EA011862B1 (ru) * 2004-03-24 2009-06-30 Актавис Груп Хф. Композиции рамиприла
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2419970C3 (de) * 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
JPS5283547A (en) * 1976-01-01 1977-07-12 Hoechst Ag Tertiary cyclic amine
DE2655331A1 (de) * 1976-12-07 1978-06-08 Hoechst Ag Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung
EP0243891B1 (en) * 1986-04-29 1991-08-14 Hoechst-Roussel Pharmaceuticals Incorporated A laminar structure for administering a chemical at a controlled release rate
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
JPH05230044A (ja) * 1992-02-21 1993-09-07 Hoechst Japan Ltd ピレタニドの新規な結晶多形

Also Published As

Publication number Publication date
GR3034605T3 (en) 2001-01-31
PT812320E (pt) 2000-12-29
DE69609314T2 (de) 2001-06-13
DK0812320T3 (da) 2003-04-14
EP0812320B1 (en) 2000-07-12
CN1175948A (zh) 1998-03-11
MX9706339A (es) 1998-07-31
KR19980702374A (ko) 1998-07-15
WO1996026197A1 (en) 1996-08-29
ES2150105T3 (es) 2000-11-16
EP0812320A1 (en) 1997-12-17
ATE194607T1 (de) 2000-07-15
CA2213693C (en) 2008-04-15
KR100419355B1 (ko) 2004-06-04
BR9607295A (pt) 1997-11-25
US6096779A (en) 2000-08-01
CN1072215C (zh) 2001-10-03
DE69609314D1 (de) 2000-08-17
CA2213693A1 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
EG20218A (en) Process for preparing of substituted 3 aminoquinuclidines
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
ZA953701B (en) New atagonist compounds
YU43694A (sh) Magnezijum omeprazol i postupak za dobijanje ovog jedinjenja
GR3035479T3 (en) Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines.
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
AU684914B2 (en) 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
HK1006783A1 (en) Amorphous piretanide, piretanide polymorphis, process for their preparation and their use
ZA887399B (en) 4-aminopyridine derivatives
GB9310095D0 (en) Therapeutic compounds
IL115301A0 (en) Process for the manufacture of starch products
HU9602413D0 (en) Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
AU1579688A (en) Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation
HU9501925D0 (en) Ortho-amine-substituted benzoyl-guanidine derivatives, process for producing them their pharmaceutical or diagnostical use, and pharmaceutical compositions containing them
NO975921L (no) Fremstilling av bicykloheksanderivater
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
GR3031267T3 (en) Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals.
AU4442389A (en) 1,2,3,4-tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
CA2208630A1 (en) 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUT74290A (en) Process for the preparation of indolizine derivatives and the starting compound
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds
AU1099688A (en) Substituted 3-phenyl-7h-thiazolo(2,2-b)(1,2,4)triazin-7-ones, a process for the preparation thereof, medicaments containing same and the use thereof, and also some intermediates formed in the preparation of the compounds mentioned
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20160211